The FDA has approved fitusiran, now Qfitlia, as a treatment for hemophilia A or B patients, ages 12 and older, with or ...

Columnist Alliah Czarielle, who's experienced the ups and downs of her husband's hemophilia, savors time when nothing special is going on.

Alhemo prophylaxis is linked to better quality of life and a lower treatment burden for hemophilia patients without ...

Columnist G. Shellye Horowitz chats with Hannes Jung, creator of the Bleeder app, which helps hemophilia patients track ...

About 30% of people hospitalized due to acquired hemophilia have a bleeding event, while 17% have a blood clot-related ...

Due to hemophilia A patients switching to newer treatments, Takeda Pharmaceuticals is discontinuing both Hemofil M and ...

This year's Manila Pen Show felt extra special for columnist Alliah Czarielle and her family. It was a lesson on finding ...

It’s that time of year again when brackets are busted, Cinderella stories happen, and basketball fans everywhere are glued to the television for the madness of March. The NCAA basketball tournament is ...

At an international conference, columnist G Shellye Horowitz has a bleed that spurs questions about how women with hemophilia ...

Although no cure for hemophilia is currently available, a number of therapies can be used to control bleeding and other symptoms. These treatments can substantially increase life expectancy by ...

A recent gathering of the New Mexico bleeding disorders community provided many opportunities for support, columnist Joe MacDonald says.